DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

Data Compilation
#PharmaFlow

Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

Stock Recap
#PipelineProspector

Triamcinolone Acetonide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

53 API Suppliers, 28 USDMF, 10 CEP/COS, 5 JDMF, 6 EU WC, 22 KDMF, 26 NDC API, 1 VMF, 28 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

28 Drugs in Development

28 Drugs in Development

FINISHED DOSAGE FORMULATIONS

282 FDF Dossiers, 228 FDA Orange Book, 12 Europe, 17 Canada, 2 South Africa, 23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.025% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 10MG/ML, SPRAY;TOPICAL - 0.147MG/GM, INJECTABLE;INJECTION - 40MG/ML, INJECTABLE;INJECTION - 80MG/ML, SPRAY, METERED;NASAL - 0.055MG/SPRAY, FOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR - 32MG/VIAL, CREAM;TOPICAL - 0.025%, CREAM;TOPICAL - 0.1%, CREAM;TOPICAL - 0.5%, OINTMENT;TOPICAL - 0.025%, OINTMENT;TOPICAL - 0.1%, OINTMENT;TOPICAL - 0.5%

RELATED EXCIPIENT COMPANIES

4 Rochem International Inc, 9 SPI Pharma, 2 Seqens, 11 DKSH, 1 Jai Radhe Sales, 1 Pharm-RX Chemical, 7 Gangwal Healthcare, 13 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 15 Actylis, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 22 BASF, 1 Clariant, 2 DFE Pharma, 6 Finar, 12 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 8 Kerry, 1 Kima Chemical, 3 Lonza Capsugel, 11 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 1 Prachin Chemical, 1 Qualicaps, 19 Roquette, 12 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 1 The Dow Chemical Company, 1 Valens Pharmachem, 1 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

41 Topical, 39 Solubilizers, 38 Thickeners and Stabilizers, 28 Fillers, Diluents & Binders, 27 Parenteral, 19 Film Formers & Plasticizers, 18 Direct Compression, 17 Emulsifying Agents, 16 Co-Processed Excipients, 15 Coating Systems & Additives, 13 Surfactant & Foaming Agents, 10 Controlled & Modified Release, 8 Taste Masking, 8 Rheology Modifiers, 8 Empty Capsules, 8 Granulation, 6 Disintegrants & Superdisintegrants, 5 Chewable & Orodispersible Aids, 5 Lubricants & Glidants, 3 API Stability Enhancers, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

103 NEWS #PharmaBuzz

103 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 34 Finished Drug Prices

MARKET PLACE

26 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents, 1 US Exclusivities, 4 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 USP, 2 JP, 4 Others

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
28/10/2024	Axplora	Germany	Farmabios SpA Gropello Cairoli IT	R0-CEP 2021-315 - Rev 00	Triamcinolone acetonide, Process 2, micronised and non-micronised	2021-12-21	Valid	Chemical		533
28/10/2024	Coral Drugs Private Limited	India	CORAL DRUGS PRIVATE LIMITED New Delhi IN	CEP 2017-167 - Rev 02	Triamcinolone acetonide, Micronised	2024-05-27	Valid	Chemical		533

Triamcinolone Acetonide

Triamcinolone Acetonide

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

53 API Suppliers

28 USDMF

10 CEP/COS

5 JDMF

6 EU WC

22 KDMF

26 NDC API

1 VMF

28 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

28 Drugs in Development

FINISHED DOSAGE FORMULATIONS

282 FDF Dossiers

228 FDA Orange Book

12 Europe

17 Canada

2 South Africa

23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.025% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 10MG/ML

SPRAY;TOPICAL - 0.147MG/GM

INJECTABLE;INJECTION - 40MG/ML

INJECTABLE;INJECTION - 80MG/ML

SPRAY, METERED;NASAL - 0.055MG/SPRAY

FOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR - 32MG/VIAL

CREAM;TOPICAL - 0.025%

CREAM;TOPICAL - 0.1%

CREAM;TOPICAL - 0.5%

OINTMENT;TOPICAL - 0.025%

OINTMENT;TOPICAL - 0.1%

OINTMENT;TOPICAL - 0.5%

RELATED EXCIPIENT COMPANIES

4 Rochem International Inc

9 SPI Pharma

2 Seqens

11 DKSH

1 Jai Radhe Sales

1 Pharm-RX Chemical

7 Gangwal Healthcare

13 Nanjing Well Pharmaceutical

4 ACG Worldwide

15 Actylis

2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

22 BASF

1 Clariant

2 DFE Pharma

6 Finar

12 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

8 Kerry

1 Kima Chemical

3 Lonza Capsugel

11 Microlex e.U

1 Nanjing Bold Chemical

2 Nomisma Healthcare

1 Pharmatrans-Sanaq

3 Pluviaendo

1 Prachin Chemical

1 Qualicaps

19 Roquette

12 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

8 Sigachi Industries

1 The Dow Chemical Company

1 Valens Pharmachem

1 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

41 Topical

CREAM;TOPICAL - 0.025% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CREAM;TOPICAL - 0.1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons